263 related articles for article (PubMed ID: 1394142)
1. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
[TBL] [Abstract][Full Text] [Related]
2. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise.
Tymchuk CN; Tessler SB; Barnard RJ
Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592
[TBL] [Abstract][Full Text] [Related]
3. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
Jordan VC; Fritz NF; Tormey DC
Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
[TBL] [Abstract][Full Text] [Related]
4. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
5. Estradiol binding to plasma proteins after changing to a low-fat diet.
Ingram D; Bennett F; Wood A
Nutr Cancer; 1989; 12(4):327-32. PubMed ID: 2608537
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of estradiol as a marker for breast cancer risk assessment.
Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
[TBL] [Abstract][Full Text] [Related]
7. The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients.
Rose DP; Connolly JM; Chlebowski RT; Buzzard IM; Wynder EL
Breast Cancer Res Treat; 1993 Sep; 27(3):253-62. PubMed ID: 8312583
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
Ellmén J; Hakulinen P; Partanen A; Hayes DF
Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
[TBL] [Abstract][Full Text] [Related]
9. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Rose DP; Davis TE
Cancer Res; 1980 Nov; 40(11):4043-7. PubMed ID: 6451282
[TBL] [Abstract][Full Text] [Related]
10. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
11. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.
Jordan VC; Fritz NF; Tormey DC
Cancer Res; 1987 Aug; 47(16):4517-9. PubMed ID: 3607780
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Murayama Y
Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
15. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls.
Takatani O; Kosano H; Okumoto T; Akamatsu K; Tamakuma S; Hiraide H
J Natl Cancer Inst; 1987 Dec; 79(6):1199-204. PubMed ID: 3480371
[TBL] [Abstract][Full Text] [Related]
16. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial.
Berrino F; Bellati C; Secreto G; Camerini E; Pala V; Panico S; Allegro G; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):25-33. PubMed ID: 11205485
[TBL] [Abstract][Full Text] [Related]
17. The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study).
Gann PH; Chatterton RT; Gapstur SM; Liu K; Garside D; Giovanazzi S; Thedford K; Van Horn L
Cancer; 2003 Nov; 98(9):1870-9. PubMed ID: 14584069
[TBL] [Abstract][Full Text] [Related]
18. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.
Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1296-301. PubMed ID: 15298949
[TBL] [Abstract][Full Text] [Related]
19. [Sex hormone-binding globulin in breast cancer].
Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
[TBL] [Abstract][Full Text] [Related]
20. Reliability of measurements of total, protein-bound, and unbound estradiol in serum.
Toniolo P; Koenig KL; Pasternack BS; Banerjee S; Rosenberg C; Shore RE; Strax P; Levitz M
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):47-50. PubMed ID: 8118385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
